Coherus Oncology, Inc.

CHRS · XNAS

CIK 1512762fmd_1AKC87E1HWGQ2SPEEACG7D60BBManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2012 to Sep 30, 2026, 56 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.